Tag: non-Hodgkin lymphoma

$Englumafusp Alfa and Glofitamab Show Promise in Relapsed or Refractory B Cell Lymphoma$

July 17, 2026

Englumafusp Alfa and Glofitamab Show Promise in Relapsed or Refractory B Cell Lymphoma

Epcoritamab LBCL: Durable Response Analysis

June 15, 2025

Epcoritamab LBCL: Durable Response Analysis

Web Analytics Made Easy - Statcounter